drugset / Trial / NCT01828892
Glue Application in the Treatment of Low-Output Fistulas
RandomizedParallel-groupOpen-labelTreatment
Summary
Adjuvant use of fibrin glue (FG) in the fistula tract has been shown to promote closure of low-output enterocutaneous fistulas (ECFs). The primary objectives of this study are to compare the clinical efficacy, safety of autologous platelet-rich fibrin glue (PRFG), commercial fibrin glue, and control therapy in the management of patients with low-output volume ECFs.
Timeline
- Start
- 2014-03
- Primary completion
- 2017-06
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cefotaxime | Small molecule | — | — |
| Background | Ceftazidime | Small molecule | — | — |
| Background | Meropenem | Small molecule | — | — |
| Background | Vancomycin | Other / unclassified | — | — |